SARS-CoV-2 vaccines for all but a single dose for COVID-19 survivors

• Matthew Frieman,
• Anthony D. Harris,
• Ramin Sedaghat Herati,
• Florian Krammer,
• Alberto Mantovani,
• Maria Rescigno,
• Mohammad M. Sajadi,
• Viviana Simon

Affiliations

Matthew Frieman

Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, United States

Anthony D. Harris

Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland, United States; Department of Medicine, Baltimore VA Medical Center, Baltimore, Maryland, United States

Ramin Sedaghat Herati

New York University School of Medicine, New York City, NY, United States

Florian Krammer

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, United States

Alberto Mantovani

Department of Biomedical Sciences, Humanitas University, Milan, Italy; IRCCS Humanitas Research Hospital, Milan, Italy; The William Harvey Research Institute, Queen Mary University, London, United Kingdom

Maria Rescigno

Department of Biomedical Sciences, Humanitas University, Milan, Italy; IRCCS Humanitas Research Hospital, Milan, Italy

Mohammad M. Sajadi

Department of Medicine, Baltimore VA Medical Center, Baltimore, Maryland, United States; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, United States; Global Virus Network, Baltimore, Maryland, United States

Viviana Simon

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, United States; Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States; Global Health Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States; Corresponding author.